Premature Menopause Associated With Increased Long-Term Cardiovascular Risk
Premature menopause, defined as either surgical or natural menopause before 40 years of age, is associated with an increased risk for cardiovascular disease.
Menopause
MENOPAUSE
Featured Article
Latest News
Lower Education, Hepatitis C Co-Infection Linked to Earlier Menopause in HIV
In women with HIV, lower education and hepatitis C co-infection are independently associated with the onset of menopause before age 45 years.
Physical Activity May Lower Postmenopausal Fracture Risk
For postmenopausal women, physical activity is associated with reduced risks for total fracture and hip fracture.
Extended Estrogen Therapy Aids Late-Life Cognition
Longer use of estrogen hormone therapy is associated with higher cognitive status in late life.
Fractionated CO2 Laser Treatment Similar to Estrogen Therapy for Menopause
Similar improvement seen in genitourinary syndrome of menopause symptoms, sexual function
Hysterectomy Linked to Long-Term Risk for Depression, Anxiety
Hysterectomy, even with ovarian conservation, is associated with an increased long-term risk for de novo depression.
Discussing Postmenopausal Vulvovaginal Symptoms at a Well-Woman Visit
Researchers sought to determine patient and visit characteristics associated with the discussion of postmenopausal vulvovaginal symptoms at well-woman examinations.
Inclusion of Additional Clinical Factors Does Not Improve FRAX Performance in Postmenopausal Women
Researchers sought to assess the ability of the Fracture Risk Assessment Tool to discriminate between women who do and do not experience major osteoporotic fractures.
Vasomotor Symptoms at Menopause Linked to Increased Risk for CVD Events
Frequent or persistent vasomotor symptoms during the menopause transition are associated with increased risk for later cardiovascular disease events.
Higher Estradiol Dose Improves Metabolic Profile in Early But Not Late Postmenopausal Women
Higher estradiol doses had significant benefits for cardiovascular risk factors in early postmenopausal women, but these effects were attenuated in late postmenopausal women.
Fezolinetant Reduces Frequency, Severity of Vasomotor Symptoms in Menopause
The neurokinin 3 receptor antagonist fezolinetant reduces the frequency and severity of vasomotor symptoms in menopause.
Leisure-Time Physical Activity May Attenuate Menopause-Associated Atherogenic Changes
The menopausal transition may be a stronger determinant of serum cardiovascular risk factors than chronologic age.
Want to read more?
Please login or register first to view this content.
